While Daley, President of the International Society for stem Cell Research, is enthusiastic about the promise of reprogramming studies, he is far from having to abandon experiments with embryonic stem cells. Daley believes that reprogramming and ESC research must be encouraged in tandem to bring cell therapy to the clinic as quickly as possible.
Daley and his colleagues of the first author and children researcher In Hyun Park, intentionally produced some stem cell lines for , single, single-gene diseases such as Gaucher’s disease, complex genetic syndromes, such as Down and then complex diseases such as Parkinson’s disease, genetic genetic, cellular, and perhaps environmental components.Y released. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.